Zhejiang Jiuzhou Pharmaceutical Hits Day High with 8.5% Surge

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.5% on August 13, 2026. The stock reached an intraday high of CNY 18.51, marking a notable achievement in a challenging market environment. In comparison to the China Shanghai Composite, which saw a decline of 0.5% on the same day, Zhejiang Jiuzhou's performance stands out. Over the past week, the stock has surged by 20.29%, and its one-month performance reflects a robust increase of 24.73%. However, the stock has faced challenges over the longer term, with a one-year performance of -4.3% and a three-year decline of 35.73%. Financial metrics indicate that the company maintains a return on equity (ROE) of 7.55% and a price-to-book ratio of 1.93, suggesting an attractive valuation. Additionally, the stock offers a dividend yield of 1.82%, contributing to its appeal among investors. Overall, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. continues to navigate a complex market landscape while demonstrating resilience in its recent performance.